Erratum: Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015))

Brooke A. Schlappe; Jennifer J. Mueller; Oliver Zivanovic; Ginger J. Gardner; Kara Long Roche; Yukio Sonoda; Dennis S. Chi; Roisin E. O'Cearbhaill

doi:10.1016/j.ygyno.2016.07.097

Erratum: Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015))

Brooke A. Schlappe, Jennifer J. Mueller, Oliver Zivanovic, Ginger J. Gardner, Kara Long Roche, Yukio Sonoda, Dennis S. Chi, Roisin E. O'Cearbhaill

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The authors regret that there was an error in one of the author names. The authors would like to apologise for any inconvenience caused.

Original language	English (US)
Pages (from-to)	225
Number of pages	1
Journal	Gynecologic oncology
Volume	143
Issue number	1
DOIs	https://doi.org/10.1016/j.ygyno.2016.07.097
State	Published - Oct 1 2016

ASJC Scopus subject areas

Oncology
Obstetrics and Gynecology

Access to Document

10.1016/j.ygyno.2016.07.097

Fingerprint

Dive into the research topics of 'Erratum: Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015))'. Together they form a unique fingerprint.

Cite this

Schlappe, B. A., Mueller, J. J., Zivanovic, O., Gardner, G. J., Long Roche, K., Sonoda, Y., Chi, D. S., & O'Cearbhaill, R. E. (2016). Erratum: Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015)). Gynecologic oncology, 143(1), 225. https://doi.org/10.1016/j.ygyno.2016.07.097

Erratum: Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015)). / Schlappe, Brooke A.; Mueller, Jennifer J.; Zivanovic, Oliver et al.
In: Gynecologic oncology, Vol. 143, No. 1, 01.10.2016, p. 225.

Research output: Contribution to journal › Comment/debate › peer-review

Schlappe, BA, Mueller, JJ, Zivanovic, O, Gardner, GJ, Long Roche, K, Sonoda, Y, Chi, DS & O'Cearbhaill, RE 2016, 'Erratum: Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015))', Gynecologic oncology, vol. 143, no. 1, pp. 225. https://doi.org/10.1016/j.ygyno.2016.07.097

Schlappe BA, Mueller JJ, Zivanovic O, Gardner GJ, Long Roche K, Sonoda Y et al. Erratum: Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015)). Gynecologic oncology. 2016 Oct 1;143(1):225. doi: 10.1016/j.ygyno.2016.07.097

Schlappe, Brooke A. ; Mueller, Jennifer J. ; Zivanovic, Oliver et al. / Erratum : Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015)). In: Gynecologic oncology. 2016 ; Vol. 143, No. 1. pp. 225.

@article{d936bb29fad64a0096ef6f7ef4ba0b71,

title = "Erratum: Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015))",

abstract = "The authors regret that there was an error in one of the author names. The authors would like to apologise for any inconvenience caused.",

author = "Schlappe, {Brooke A.} and Mueller, {Jennifer J.} and Oliver Zivanovic and Gardner, {Ginger J.} and {Long Roche}, Kara and Yukio Sonoda and Chi, {Dennis S.} and O'Cearbhaill, {Roisin E.}",

note = "Publisher Copyright: {\textcopyright} 2016 Elsevier Inc.",

year = "2016",

month = oct,

day = "1",

doi = "10.1016/j.ygyno.2016.07.097",

language = "English (US)",

volume = "143",

pages = "225",

journal = "Gynecologic oncology",

issn = "0090-8258",

publisher = "Academic Press Inc.",

number = "1",

}

TY - JOUR

T1 - Erratum

T2 - Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015))

AU - Schlappe, Brooke A.

AU - Mueller, Jennifer J.

AU - Zivanovic, Oliver

AU - Gardner, Ginger J.

AU - Long Roche, Kara

AU - Sonoda, Yukio

AU - Chi, Dennis S.

AU - O'Cearbhaill, Roisin E.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - The authors regret that there was an error in one of the author names. The authors would like to apologise for any inconvenience caused.

AB - The authors regret that there was an error in one of the author names. The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=84990175413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990175413&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2016.07.097

DO - 10.1016/j.ygyno.2016.07.097

M3 - Comment/debate

C2 - 27496397

AN - SCOPUS:84990175413

SN - 0090-8258

VL - 143

SP - 225

JO - Gynecologic oncology

JF - Gynecologic oncology

IS - 1

ER -

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this